ELAB vs NUE · rev $2.0M vs P/E 25, rev $19.89B
Elevai Labs, Inc. Common Stock (ELAB) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
ELAB currently screens at market cap $6.5M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the ELAB and NUE stock pages for the full models.
Not investment advice.